Skip to main content
Clinical Trials/IRCT20191031045289N2
IRCT20191031045289N2
Not yet recruiting
Phase 3

The effect of adding lasix to antihypertensive treatment in controlling postpartum hypertension in women with preeclampsia

Shahid Beheshti University of Medical Sciences0 sites116 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
116
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Systolic blood pressure above 150 mm Hg
  • Diastolic blood pressure above 100 mm Hg
  • Urine rate more than 50 cc per hour
  • Termination of treatment with magnesium sulfate

Exclusion Criteria

  • History of chronic hypertension
  • Blood pressure less than 150/100 mm Hg
  • Use of diuretics
  • Previous underlying renal disorders
  • Having diabetes
  • Hemodynamic instability
  • Contraindications to the use of Lasix
  • Hematocrit more than 37

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
The effect of antihypertensive treatment with Lisinopril and Labetalol on baroreflex sensitivity in strokeCardiovascular: StrokeCirculatory SystemStroke
ISRCTN37578410Record Provided by the NHSTCT Register - 2005 Update - Department of Health23
Active, not recruiting
Not Applicable
The Effect Of Antihypertensive Treatment With Lisinopril and Labetalol on Baroreflex Sensitivity in Stroke - Effect Of Lisinopril and Labetalol On BRS In StrokeStroke
EUCTR2004-004231-53-GBRoyal Devon and Exeter NHS Foundation Trust23
Completed
Not Applicable
Comparison of the effect of anti-hypertensive treatment with verapamil and amlodipine on the coronary vasodilator reserve and the transmural distribution of myocardial blood flow in hypertensive patients with left ventricular hypertrophyHypertensionCirculatory System
ISRCTN35563487Abbott (Germany)50
Completed
Not Applicable
Evaluation for drug combination of antihypertensive agent and lipid-lowering agent in patients with hypertension and dyslipidemiaHypertension and dyslipidemia
JPRN-UMIN000008539Saitama Medical Center, Saitama Medical University30
Completed
Phase 4
Combination of Antihypertensive therapy in the elderly, Multicenter Investigation <CAMUI> Multi-center randomized controlled study on efficacy of ARB/Diuretic mixture versus ARB/Ca channel blocker combination therapy to blood pressure or cognitive function in the elderly patients who have insufficient controlled hypertension in ARB monotherapyHypertension
JPRN-UMIN000001688Elderly Hypertension Conference200